Skip to main content
61°
Partly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Gamida Cell Ltd.
< Previous
1
2
Next >
Gamida Cell to Present Corporate Highlights at 2022 Cell & Gene Meeting on the Mesa
October 10, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Tickers
GMDA
Long-Term Data from Omidubicel Phase 3 Trial Demonstrates Overall Survival and Sustainable Durable Outcomes for Patients with Blood Cancers at the Society of Hematologic Oncology Meeting
September 29, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Tickers
GMDA
Gamida Cell Announces Entry into Commitment Letter with Highbridge for $25 Million Financing
September 28, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Tickers
GMDA
Gamida Cell Announces Launch of Public Offering of Ordinary Shares
September 27, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Tickers
GMDA
Gamida Cell Appoints Abigail L. Jenkins as President and Chief Executive Officer, Bringing Broad Leadership Experience in Commercializing Innovative Therapies
September 19, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Tickers
GMDA
Gamida Cell Presents Data Demonstrating the Impact of Transplantation with Omidubicel for Patients with Hematologic Malignancies at 2022 Cord Blood Connect Meeting
September 12, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Tickers
GMDA
Gamida Cell Reports Second Quarter 2022 Financial Results and Provides Company Update
August 15, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Tickers
GMDA
Gamida Cell Announces Dosing of First Patient in Company-Sponsored Phase 1/2 Study of NK Cell Therapy Candidate GDA-201
August 10, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Tickers
GMDA
Gamida Cell Announces the Date of Its Second Quarter 2022 Financial Results and Webcast
August 08, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Tickers
GMDA
Gamida Cell Announces FDA Acceptance of Biologics License Application for Omidubicel with Priority Review
August 01, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Tickers
GMDA
Gamida Cell to Present Corporate Highlights at the JMP Securities Life Sciences Conference
June 13, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Tickers
GMDA
Gamida Cell Completes Rolling Biologics License Application Submission to the FDA for Omidubicel
June 02, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Tickers
GMDA
Gamida Cell to Present Corporate Highlights at the Jefferies Healthcare Conference
June 01, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Tickers
GMDA
Gamida Cell Announces Opening to Enrollment of Company-Sponsored Phase 1/2 Study of NK Cell Therapy Candidate GDA-201
June 01, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Tickers
GMDA
Gamida Cell to Present Corporate Highlights at the H.C. Wainwright Global Life Sciences Conference
May 17, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Tickers
GMDA
Gamida Cell Reports First Quarter 2022 Financial Results and Provides Company Update
May 10, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Tickers
GMDA
Gamida Cell Presents New Data from NAM-Enabled Genetically Modified Natural Killer (NK) Pipeline at International Society for Cell & Gene Therapy 2022
May 05, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Tickers
GMDA
Gamida Cell Announces the Date of Its First Quarter 2022 Financial Results and Webcast
May 03, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Tickers
GMDA
Gamida Cell Presents Updated One-Year Post-Transplant Follow Up Data from Phase 3 Study of Omidubicel at 2022 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR Tandem Meetings
April 27, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Tickers
GMDA
Gamida Cell Presents Updated Omidubicel Data During Best Abstract Award Session at 2022 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR Tandem Meetings
April 25, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Tickers
GMDA
Gamida Cell Announces Results of New Health Economic and Outcome Study Reporting Improved Health Equity and Health Outcomes With Omidubicel at 2022 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR Tandem Meetings
April 25, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Tickers
GMDA
Gamida Cell to Present Corporate Highlights and Participate in Panel Discussion at the Needham Healthcare Conference
April 07, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Tickers
GMDA
Gamida Cell Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Company Update
March 15, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Tickers
GMDA
Gamida Cell Initiates Rolling Submission of Biologics License Application for Omidubicel
February 09, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Tickers
GMDA
Gamida Cell Announces Appointment of Anat Cohen-Dayag and Naama Halevi-Davidov to its Board of Directors
January 31, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Tickers
GMDA
Gamida Cell Provides Key Program Updates and 2022 Financial Guidance
January 31, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Tickers
GMDA
Gamida Cell Provides Update on Omidubicel BLA Submission
January 19, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Tickers
GMDA
Gamida Cell Announces Data to be Presented at 2022 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR Tandem Meetings
January 07, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Tickers
GMDA
Gamida Cell Presents Two-Year Survival Data for GDA-201 and Resource Utilization Analysis for Omidubicel at 63rd ASH Annual Meeting
December 13, 2021
From
Gamida Cell Ltd.
Via
Business Wire
Tickers
GMDA
Gamida Cell Presents New Omidubicel Data at 63rd ASH Annual Meeting
December 11, 2021
From
Gamida Cell Ltd.
Via
Business Wire
Tickers
GMDA
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.